MRKON
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.
Name MRKON
Rank No.3558
Market Cap $0,00
Fully Diluted Market Cap $0,00
Market Share %
Trading Vol/Market Cap (24H) 1.965.158,01%
Circulation Supply 51,08246944
Max Supply 0
Total Supply 51,08246944
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 124.52894410298839, 2026-02-25
Lowest Price 106.19666406291768, 2026-01-29
Public Blockchain MRKON
Introduction Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products.
Sector
Social Media
Fund Flow Analysis
|
Buy(MRKON) |
Sell(MRKON) |
Net Inflow |
| Big |
0,000 |
624,650 |
-624,650 |
| Medium |
0,000 |
0,000 |
0,000 |
| Small |
700,900 |
14,240 |
686,650 |
| Total |
700,900 |
638,890 |
62,000 |
etfindex:mc_etfindex_source Disclaimer: Data provided by cmc and should not be considered as investment advice.